Who owns GLAXFWhat GLAXF owns
What GSK plc owns
The company's own 13F portfolio · as of 2026-09-30 · long US-listed stakes only — private holdings, bonds and cash are not disclosable on a 13F
$497.0M
disclosed stock portfolio
13
positions
29%
in CRSP
Positions, as of 2026-09-30
ordered by filed value · % of book = share of the disclosed stock portfolio · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | CRSPCRISPR THERAPEUTICS AG | 2.6M | $144.3M | 29% |
| 2 | VIRVIR BIOTECHNOLOGY INC | 8.6M | $95.6M | 19.2% |
| 3 | WVEWAVE LIFE SCIENCES INC | 18.2M | $67.5M | 13.6% |
| 4 | BNTXBIONTECH SE | 668,526 | $65.7M | 13.2% |
| 5 | IDYAIDEAYA BIOSCIENCES INC | 1.3M | $51.2M | 10.3% |
| 6 | CYTKCYTOKINETICS INC | 340,434 | $22.4M | 4.5% |
| 7 | LYELLYELL IMMUNOPHARMA INC | 1.5M | $14.8M | 3% |
| 8 | SPROSPERO THERAPEUTICS INC | 9.2M | $11.1M | 2.2% |
| 9 | NKTXNKARTA INC | 3.2M | $8.3M | 1.7% |
| 10 | FULCFULCRUM THERAPEUTICS INC | 1.8M | $6.6M | 1.3% |
| 11 | BCYCBICYCLE THERAPEUTICS PLC | 1.5M | $5.6M | 1.1% |
| 12 | RGNXREGENXBIO INC | 271,456 | $2.0M | 0.4% |
| 13 | CVRXCVRX INC | 1.0M | $1.8M | 0.4% |
Source: SEC Form 13F-HR filed by GSK plc (CIK 1131399), reporting period 2026-09-30. Values are quarter-end filed marks. Research, not investment advice.